跳至主要内容
临床试验/NCT01791166
NCT01791166已完成不适用

Humoral Rejection - Diagnostic Markers in Pulmonary Transplant.

Hopital Foch2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Hopital Foch
入组人数
53
试验地点
2
主要终点
Incidence of immune Markers of acute lung transplant rejection (Anti-HLA circulatory antibodies, neutrophils and C4d immune markers.

研究概览

简要总结

Open multicentric prospective study performed on pulmonary transplanted patients to detect the values of different diagnostic markers for immuno- humoral reaction and their roles in the humoral rejection for those patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Both genders, more than 18 years of age.
  • Patients with or without Cystic fibrosis
  • Patients with no previous unilateral or bilateral pulmonary transplant or cardiopulmonary transplant
  • Patients with no current other disease can affect, in short term, the process or prognosis of the transplant
  • Patients had given his agreement to be enrolled in the study

排除标准

  • Patient less than 18 year-old
  • Patient had previous organ transplant
  • Pregnant and/or lactating women
  • Female subject in reproductive age does not use effective contraceptive methode
  • Alcoholisms or neuropsychosis, conditions that affect the good comprehension of the study

结局指标

主要结局

Incidence of immune Markers of acute lung transplant rejection (Anti-HLA circulatory antibodies, neutrophils and C4d immune markers.

时间窗: 12 months after pulmonary transplant

次要结局

未报告次要终点

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验